| Corporate Communications Manager |
London (The Westworks) |
Birleşik Krallık |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 21, 2024 |
| Corporate Communications Manager |
Madrid Delegación |
İspanya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 21, 2024 |
| Associate Director, Patient Engagement, Neuroscience and Gene Therapies |
East Hanover |
ABD |
Development |
Innovative Medicines |
Communications & Public Affairs |
Kas 20, 2024 |
| Manager, Corporate Marketing Creative & Design |
Basel (City) |
İsviçre |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 19, 2024 |
| Senior Communications & Patient Advocacy Manager |
Bogota (Pharmaceuticals / GDD / NTO / CTS) |
Kolombiya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 19, 2024 |
| Vice President of European Public Affairs |
Vilvoorde |
Belçika |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Kas 14, 2024 |
| Therapy Area Communications & Patient Advocacy Manager |
Barcelona Gran Vía |
İspanya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 14, 2024 |
| Therapy Area Communications & Patient Advocacy & Disease Agnostic Lead, Spain |
Barcelona Gran Vía |
İspanya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 14, 2024 |
| Communications & Patient Advocacy Sr. Specialist (1 yr contract) |
Seoul |
Güney Kore |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 13, 2024 |
| Associate Director, Issue Advocacy & Strategic Alliances |
Washington, DC |
ABD |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 11, 2024 |
| Senior Manager, Site Communications Basel |
Basel (City) |
İsviçre |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 11, 2024 |
| Director, Issue Advocacy & Portfolio Strategy |
Washington, DC |
ABD |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 11, 2024 |
| Directeur Affaires Publiques Aire Thérapeutique H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
Fransa |
International |
Innovative Medicines |
Communications & Public Affairs |
Kas 08, 2024 |
| Director of Policy Communications and Media Relations, Europe |
Basel (City) |
İsviçre |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 07, 2024 |
| Communications & Patient Advocacy Manager |
Selangor |
Malezya |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Kas 06, 2024 |
| Lead - Government Affairs |
Delhi (Office) |
Hindistan |
International |
Innovative Medicines |
Communications & Public Affairs |
Kas 05, 2024 |
| Executive Director, Therapy Area Communications and Patient Advocacy |
Basel (City) |
İsviçre |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 04, 2024 |
| Communication & Patient Advocacy Manager (f/m/d) |
Vienna |
Avusturya |
International |
CTS |
Communications & Public Affairs |
Eki 31, 2024 |
| Associate Director, Business Transformation & Engagement |
Barcelona Gran Vía |
İspanya |
Development |
Innovative Medicines |
Communications & Public Affairs |
Eki 23, 2024 |
| Government Affairs Manager |
Moscow (City) |
Rusya Fede. |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Eki 22, 2024 |
| (Sr.) Public Affairs Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Communications & Public Affairs |
Eki 20, 2024 |
| Comms & Engagement Manager |
Amsterdam |
Hollanda |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Eki 16, 2024 |
| Associate Director, R&D Portfolio and Engagement - Communications |
Cambridge (Massachusetts) |
ABD |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Eki 08, 2024 |
| Public Affairs Manager |
Ankara Gimat |
Türkiye |
International |
Innovative Medicines |
Communications & Public Affairs |
Eyl 13, 2024 |
| Patient Engagement Lead |
İstanbul Kavacık |
Türkiye |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Eyl 03, 2024 |
| Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Almanya |
International |
Innovative Medicines |
Communications & Public Affairs |
Tem 09, 2024 |